anon_gidy said in #5424 23h ago:
Perhaps Hanania’s most noteworthy intellectual contribution was to ‘expose’ the legal basis of the proliferation of wokeness: the disparate impact doctrine. This implied a legal/administrative agenda to combat wokeness.
I want to propose that a similar dynamic is at play vis-a-vis ‘managerialism’. The separation of ownership and control looks like the inevitable product of corporate scale and diffuse shareholding, but is substantially a legal artifact.There are 2 main legal & bureaucratic structures that protect managerialism against activist investors. First, SEC mandates certain disclosure requirements and imposes restrictions to investors based on their ownership stakes with the thresholds set at 5% and 10%. Secondly, and much more importantly, many firms adopt poison pill provisions.
The SEC regulations are as follows:
After crossing 5% ownership, you need to disclose your stake within 5 days. Thereafter, any change of one percentage point or more in your holding must be reported within two business days.
After crossing 10% ownership you additionally become a statutory insider. This adds three things on top of the 5% disclosure: (1) you must report every transaction, regardless of size, within two business days (2) the short-swing profit rule claws back to the company any profit on a purchase-and-sale pair made within any six-month window and (3) you can’t short the company's stock
The disclosure raises the cost of accumulation, as others can trade ahead of your further buying. But I like the short-swing rule to incentivize a long term mindset.
The actual impediment to activist investing or hostile takeovers, however, is the poison pill provision. Broadly speaking, a poison pill is, once a shareholder crosses a threshold around 10-20% (the exact threshold depends on the company), without the board’s approval, every other shareholder gets the option to buy additional stock for much cheaper, thereby diluting the activist who was trying to accumulate an ownership stake.
This makes it so that de facto control belongs to the board and not to an activist investor who thinks they can do a better job running the company. The poison pill was invented by Martin Lipton of Wachtell, Lipton in 1982, as a response to the hostile takeover wave of the 80s by ‘corporate raiders’ such as T. Boone Pickens and Carl Icahn.
When challenged at court, the poison pill was found to be legal (Moran v. Household, Del. 1985). The poison pill, coupled with Milken, who financed a lot of this activity with junk bonds, going to jail, ended the corporate raiding wave. With the rise of passive investing, managerial control over public corporations is stronger than ever.
I’ve picked biotech stock investing as a hobby recently. And, in that industry, many companies are worth in the 100s of millions to low single digit billions of dollars range. Many biotech funds then are in a position to act as owners. At the same time, in SMID biotech investing management quality is considered paramount. What happens is, instead of these funds changing the management they perceive to be low quality, they decide instead to just pass. It’s not worth it to try to change and deal with bad management.
So to sum up, insofar as we want to return to a more entrepreneurial and old-school form of capitalism, we need to think about legal reforms that enable this outcome, including but not limited to banning poison pill provisions.
I want to propose that a similar dynamic is at play vis-a-vis ‘managerialism’. The separation of ownership and control looks like the inevitable product of corporate scale and diffuse shareholding, but is substantially a legal artifact.There are 2 main legal & bureaucratic structures that protect managerialism against activist investors. First, SEC mandates certain disclosure requirements and imposes restrictions to investors based on their ownership stakes with the thresholds set at 5% and 10%. Secondly, and much more importantly, many firms adopt poison pill provisions.
The SEC regulations are as follows:
After crossing 5% ownership, you need to disclose your stake within 5 days. Thereafter, any change of one percentage point or more in your holding must be reported within two business days.
After crossing 10% ownership you additionally become a statutory insider. This adds three things on top of the 5% disclosure: (1) you must report every transaction, regardless of size, within two business days (2) the short-swing profit rule claws back to the company any profit on a purchase-and-sale pair made within any six-month window and (3) you can’t short the company's stock
The disclosure raises the cost of accumulation, as others can trade ahead of your further buying. But I like the short-swing rule to incentivize a long term mindset.
The actual impediment to activist investing or hostile takeovers, however, is the poison pill provision. Broadly speaking, a poison pill is, once a shareholder crosses a threshold around 10-20% (the exact threshold depends on the company), without the board’s approval, every other shareholder gets the option to buy additional stock for much cheaper, thereby diluting the activist who was trying to accumulate an ownership stake.
This makes it so that de facto control belongs to the board and not to an activist investor who thinks they can do a better job running the company. The poison pill was invented by Martin Lipton of Wachtell, Lipton in 1982, as a response to the hostile takeover wave of the 80s by ‘corporate raiders’ such as T. Boone Pickens and Carl Icahn.
When challenged at court, the poison pill was found to be legal (Moran v. Household, Del. 1985). The poison pill, coupled with Milken, who financed a lot of this activity with junk bonds, going to jail, ended the corporate raiding wave. With the rise of passive investing, managerial control over public corporations is stronger than ever.
I’ve picked biotech stock investing as a hobby recently. And, in that industry, many companies are worth in the 100s of millions to low single digit billions of dollars range. Many biotech funds then are in a position to act as owners. At the same time, in SMID biotech investing management quality is considered paramount. What happens is, instead of these funds changing the management they perceive to be low quality, they decide instead to just pass. It’s not worth it to try to change and deal with bad management.
So to sum up, insofar as we want to return to a more entrepreneurial and old-school form of capitalism, we need to think about legal reforms that enable this outcome, including but not limited to banning poison pill provisions.
Perhaps Hanania’s mo